Discontinuing risperidone linked to agitation in Alzheimer's
Prenatal antidepressant exposure not linked to intellectual, behavioral effects
Rhabdomyolysis linked to pregabalin and simvastatin
Bipolar patients at higher risk for adverse pregnancy outcomes
FDA: Benefits of new obesity drugs greater than risks
Study examines risk for cardiovascular events of varenicline vs. bupropion
Scopolamine augmentation for moderate to severe depression
From the FDA